Latest BNC210 Data Presented at Major International Conference
- New data on the mode of action of BNC210 to be presented:
- Establishes molecular link between the neurotrophic properties of
BNC210 and its anxiolytic activity.
- Encouraging support for the clinical development of BNC210 which has
been shown to have anti-anxiety and antidepressant effects and potent
promotion of neurite outgrowth in primary neurons.
- Clinical data from the successful trial comparing BNC210 to Lorazepam also
to be presented:
- BNC210 had none of the key side effects of Lorazepam.
- EEG data showed BNC210 brain activity indicates anxiolytic activity
without sedation.
- BNC210 did not produce feelings associated with drugs of abuse and
had no adverse effect on mood.
Download this document
